Tilray | TRLY - Current Assets

Stock Price
9.43
Daily Change
-0.05 -0.53%
Monthly
-8.09%
Yearly
925.00%
Q1 Forecast
9.24

Tilray reported $688.63M in Current Assets for its fiscal quarter ending in March of 2025.





Current Assets Change Date
Acasti Pharma USD 17.3M 3.22M Sep/2025
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Cronos Group USD 944.09M 21.94M Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Moderna USD 6.54B 54M Dec/2025
Organigram Holdings CAD 284.9M 7.11M Sep/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Tilray USD 688.63M 2.34M Mar/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025